These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5356984)

  • 1. Fibrin-fibrinogen degradation products in sera of normal infants and children.
    Uttley WS; Allan AG; Cash JD
    Arch Dis Child; 1969 Dec; 44(238):761-4. PubMed ID: 5356984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
    Karpinskaia VM
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
    [No Abstract]   [Full Text] [Related]  

  • 3. Staphylococcal clumping on microtiter plates: a rapid, simple method for measuring fibrinogen split products.
    Leavelle DE; Mertens BF; Bowie EJ; Owen CA
    Am J Clin Pathol; 1971 Apr; 55(4):452-7. PubMed ID: 5554198
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin degradation products in thrombo-embolic disease.
    Sonnabend D; Cooper D; Fiddes P; Penny R
    Pathology; 1972 Jan; 4(1):47-51. PubMed ID: 4622192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolysis, fibrinogen and stability of fibrin in the newborn infants].
    Hrodek O
    Cesk Pediatr; 1973 Feb; 28(2):54-7. PubMed ID: 4686576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
    Steichele DF; Herschlein HJ
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):462-74. PubMed ID: 5590239
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrin(ogen) degradation products and platelets in meningococcal infection.
    Fumarola D; Marcuccio L; Pasquetto N
    Quad Sclavo Diagn; 1973 Dec; 9(4):887-92. PubMed ID: 4213439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of fibrin degradation products in the blood of normal infants.
    Chessells JM
    Biol Neonate; 1971; 17(3):219-26. PubMed ID: 5550192
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrin degradation products in pre-eclamptic toxaemia and eclampsia.
    Henderson AH; Pugsley DJ; Thomas DP
    Br Med J; 1970 Sep; 3(5722):545-7. PubMed ID: 5454355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of staphylococcal clumping test and its clinical application].
    Nakazawa S; Meguro T; Yamada Z; Yamada K
    Rinsho Ketsueki; 1972 Jun; 13(3):363-9. PubMed ID: 4674966
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin lysis by thrombin elevating levels of fibrinogen and fibrin-related antigen (FR-antigen) in human serum as shown by Auto Analyzer assay.
    Merskey C; Johnson AJ; Lalezari P
    J Clin Pathol; 1972 Jul; 25(7):623. PubMed ID: 5070262
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple passive hemagglutination-inhibition technic for determination of fibrin degradation products and fibrinogen.
    Petchclai B; Prasongsom S
    Am J Clin Pathol; 1974 Feb; 61(2):166-8. PubMed ID: 4204530
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of methods for the detection and quantitation of serum fibrin-fibrinogen degradation products.
    Erickson C; String T; Stewart D; Cohen RJ
    Am J Clin Pathol; 1972 Oct; 58(4):394-9. PubMed ID: 4674336
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin-fibrinogin degradation products in cardiovascular surgery.
    Call FL; Schroeder ET; Parker FB; Davey FR
    Arch Surg; 1973 Dec; 107(6):834-7. PubMed ID: 4751825
    [No Abstract]   [Full Text] [Related]  

  • 19. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.
    Marder VJ; Matchett MO; Sherry S
    Am J Med; 1971 Jul; 51(1):71-82. PubMed ID: 4998883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.